1. |
陳林. 肝臟非實質細胞在肝臟病理生理過程中的作用 [J]. 國外醫學病理生理與臨床分冊, 1995; 15(1)∶51.
|
2. |
王志偉,黃宇琦.肝臟缺血再灌注損傷 [J]. 中國普外基礎與臨床雜志, 1998; 5(4)∶253.
|
3. |
湯禮軍.肝臟缺血再灌注損傷介質的研究現狀 [J]. 肝膽外科雜志, 1998; 6(2)∶318.
|
4. |
Ishikawa T, Yamamoto Y, Takeuchi K. Relationship between peri and postoperative plasma concentration of endothelin1 and liver dysfunction in rat liver transplantation [J]. Transplant Proc, 1995; 27(1)∶524.
|
5. |
Natori S, Fujii Y, Kurosawa H, et al. Prostaglandine E1 protects against ischemiareperfusion injury of the liver by inhibition of neutrophil adherence to endothelial cells [J]. Transplantation, 1997; 64(11)∶1514.
|
6. |
賈因堂,王守義,解中堅.前列腺素E1對腫瘤壞死因子水平及磷脂酶A2活性的影響 [J]. 中華肝病雜志, 1997; 5(3)∶172.
|
7. |
Xu HS, Rosenlof LK, Rruett TL, et al. Prostaglandin E1 increases survival with extended anhepatic phase during liver transplantation [J]. Ann Surg, 1994; 220(1)∶53.
|
8. |
Greig PD, Woolf GM, Sinclair SB, et al. Treatment of primary liver graft nonfunction with prostaglandin E1 [J]. Transplantation, 1989; 48(3)∶447.
|